Skip to Content

Available Cancer Clinical Trials

Explore your options for participating in a clinical trial at the Rush Copley Cancer Care Center. Clinical trials are are designed to advance scientific knowledge while protecting trial participants.

Clinical trials have guidelines that detail certain criteria researchers are looking for in participants. These often include type and stage of cancer, other medical conditions you may have, and previous treatments you have received. Talk to your doctor to determine if you meet the criteria and are eligible to participate.

Bladder Cancer

Alliance A031501: Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer

ECOG-ACRIN EA8141: Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer

Brain Cancer

Alliance A071102: Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Alliance A221101: Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma

Alliance A221208: Corticosteroids with or without Bevacizumab in Improving Symptoms in Patients with Radionecrosis after Radiation Surgery for Brain Metastasis

Breast Cancer

Alliance A011106: Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery

Alliance A011202: Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy

Alliance A011401: Breast Cancer WEight Loss Study (BWEL Study)

Alliance A011502: Aspirin in Preventing Recurrence of Cancer in Patients With Node Positive HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy

Alliance A221405: Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer (POSITIVE)

BCCR: Breast Cancer Collaborative Registry

ECOG-ACRIN EA1131: Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy

ECOG-ACRIN EAY131: NCI-MATCH: Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors or Lymphomas

ECOG E1Z11: Anastrozole in Treating Aromatase Inhibitor Musculoskeletal Symptoms in Female Patients with Stage I-III Breast Cancer

ECOG-ACRIN E2112: Exemestane With or Without Entinostat in Treating Postmenopausal Patients With Recurrent Hormone Receptor-Positive Breast Cancer That Is Locally Advanced or Metastatic

NRG BR002: Standard of Care Therapy With or Without Stereotactic Radiosurgery and/or Surgery in Treating Patients With Limited Metastatic Breast Cancer

NRG BR003: Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel with or without Carboplatin in Treating Patients with Triple-Negative Breast Cancer

NSABP B-51: Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery

NSABP B-55: Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer. (OlympiA)

RTOG 1119: Whole-Brain Radiation Therapy or Stereotactic Radiosurgery with or without Lapatinib Ditosylate in Treating Patients with Brain Metastasis from HER2-Positive Breast Cancer

SWOG S1207: Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer

SWOG S1416: Cisplatin With or Without Veliparib in Treating Patients With Stage IV Triple-Negative and/or BRCA Mutation-Associated Breast Cancer

SWOG S1418: Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer

Colorectal Cancer

Alliance N1048: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery

ECOG-ACRIN EAY131: NCI-MATCH: Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors or Lymphomas

NRG-GI002: Veliparib and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer

Gynecologic Cancer

Cervical Cancer

GOG 0263: Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery

NRG-GY006: Radiation Therapy and Cisplatin With or Without Triapine in Treating Patients With Newly Diagnosed Stage IB2, II, or IIIB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancer

Endometrial (Uterine) Cancer

NRG GOG 0286B: Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer

Ovarian Cancer

GOG 0225: Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Other

GOG 279: Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva

Head & Neck Cancer

Alliance A091404: Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers

ECOG-ACRIN EA3132: Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

NRG HN001: Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

NRG HN003: The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT

RTOG 0920: Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer

RTOG 1216: Radiation Therapy With Cisplatin, Docetaxel, or Cetuximab After Surgery in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer

Leukemia

NHLBI-MDS: The National Myelodysplastic Syndromes (MDS) Study (MDS)

SWOG S1318: Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia

Liver Cancer

NRG GI001: Gemcitabine Hydrochloride and Cisplatin With or Without Radiation Therapy in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgery

Lung Cancer

Non-Small Cell Lung Cancer

Alliance A081105: Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)

Alliance A151216: Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery

Alliance A211401: Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes

NRG LU001: Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer

SWOG S1400: Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IIIB-IV Squamous Cell Lung Cancer

SWOG S1403: Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer

Small Cell Lung Cancer

Alliance CALGB 30610: Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide

Alliance A211401: Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes

Lymphoma

Non-Hodgkin’s

ECOG-ACRIN E1412: Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma

ECOG E2408: Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma

Melanoma

ECOG E3611: Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery

ECOG-ACRIN E3612: Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

Multiple Myeloma

ECOG-ACRIN E1A11: Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

Pancreatic Cancer

RTOG 0848: Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery

Prostate Cancer

Alliance A031201: Enzalutamide With or Without Abiraterone Acetate and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer

RTOG 0924: Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

SWOG S1216: Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer

Renal Cell Carcinoma (Kidney Cancer)

ECOG E2810: Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery

SWOG S0931: Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery

Sarcoma

Alliance A091202: Study of the Peroxisome Proliferator-Activated Receptor Gamma Agonist, Efatutazone vs. Placebo in Patients With Previously Treated, Unresectable Myxoid Liposarcoma

Waterford Place

Cancer Support at Waterford Place

Waterford Place Cancer Resource Center, located adjacent to Rush Copley’s Aurora campus at 1310 Waterford Drive, provides services and support to anyone impacted by a cancer diagnosis. Waterford Place is a warm, welcoming environment where participants can connect with support services including mind-body classes, expressive therapies and informational programs along with a salon featuring an American Cancer Society® wig boutique. Programming focuses on the practical, from what to expect from treatment to how to balance practical concerns such as finances, working, health insurance as well as the emotional side of the disease. Regular lectures from clinical specialists and other health professionals help keep you informed on the latest research and treatment options, and on topics such as how to help caregivers and maintain relationships.